# Cothera Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cothera-bioscience

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Total disclosed funding: $30M
- Latest round: Series B (Jan 19, 2021)
- Investors on record: 8

## About

Established in 2018 and based in Hangzhou, China, Cothera Bioscience is a biotechnology company that specializes in the research and development of tumor targeting drugs. In January 2021, it closed a series B funding. The company develops innovative tumor-targeting drugs, conducting research and clinical development to address unmet needs in oncology. The company generates revenue from licensing agreements, partnerships and the development of proprietary oncology drug candidates.

## Funding rounds

- Series B, Jan 19, 2021, $30M — Legend Capital, Legend Star, New World Development Company, Langsheng Investment, Harbinger Ventures, Tsing Song Capital, CMB International Capital, Sherpa Healthcare Partners
- Series A, Jan 6, 2020 — Legend Capital, Legend Star

## Investors

- Legend Capital — Series A, Series B
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A, Series B
- New World Development Company — Series B
- Langsheng Investment (https://capitalatlas.ai/funds/langsheng-investment) — Series B
- Harbinger Ventures (https://capitalatlas.ai/funds/harbinger-ventures) — Series B
- Tsing Song Capital (https://capitalatlas.ai/funds/tsing-song-capital) — Series B
- CMB International Capital — Series B
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series B